Levin Capital Strategies’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-65,000
Closed -$104K 292
2023
Q3
$104K Buy
65,000
+15,000
+30% +$27.3K 0.01% 242
2023
Q2
$109K Sell
50,000
-75,000
-60% -$117K 0.01% 243
2023
Q1
$183K Buy
125,000
+45,000
+56% +$57.9K 0.02% 197
2022
Q4
$100K Buy
80,000
+10,000
+14% +$15.8K 0.01% 213
2022
Q3
$132K Buy
+70,000
New +$165K 0.02% 194
2022
Q2
Sell
-15,000
Closed -$52K 320
2022
Q1
$52K Buy
+15,000
New +$53K 0.01% 298
2021
Q3
Sell
-40,000
Closed -$162K 390
2021
Q2
$162K Sell
40,000
-15,000
-27% -$58.8K 0.02% 310
2021
Q1
$236K Buy
55,000
+30,000
+120% +$143K 0.03% 224
2020
Q4
$99K Buy
25,000
+10,000
+67% +$41.8K 0.01% 286
2020
Q3
$55K Sell
15,000
-85,000
-85% -$359K 0.01% 261
2020
Q2
$341K Sell
100,000
-90,000
-47% -$202K 0.05% 125
2020
Q1
$255K Buy
+190,000
New +$298K 0.04% 120
2019
Q4
Sell
-26,000
Closed -$54K 225
2019
Q3
$54K Hold
26,000
0.01% 197
2019
Q2
$63K Buy
+26,000
New +$56.7K 0.01% 202
2014
Q4
Sell
-35,000
Closed -$298K 407
2014
Q3
$298K Buy
35,000
+20,000
+133% +$176K ﹤0.01% 297
2014
Q2
$133K Buy
+15,000
New +$131K ﹤0.01% 342

Other funds holding OPK

Levin Capital Strategies's OPK Position: Q4 2023 in Review

Levin Capital Strategies sold out of Opko Health (OPK) in Q4 2023, closing a stake of 65,000 shares — an estimated $104K sold.

Levin Capital Strategies first reported a position in OPK in Q2 2014 and held it in 16 quarters. The position peaked at $341K in Q2 2020. 218 funds tracked by Wall St. Rank hold OPK as of Q4 2023.

  • Levin Capital Strategies reported no remaining Opko Health position as of Q4 2023 after selling out during the quarter.
  • Levin Capital Strategies sold 65,000 Opko Health shares in Q4 2023, an estimated $104K.
  • Levin Capital Strategies first reported a position in Opko Health in Q2 2014 and held it in 16 quarters.
  • Levin Capital Strategies's Opko Health position peaked at $341K in Q2 2020.
  • 218 funds tracked by Wall St. Rank held Opko Health as of Q4 2023.

Based on Levin Capital Strategies's 13F filing for Q4 2023, filed 6 Feb 2024.